FDA official logo
GSRS logo
PFDA official logo

SABATOLIMAB

  • UNII: 3L7R886Y06
  • Preferred Substance Name: SABATOLIMAB

  • 2252262-24-9
  • ANTI-TIM3 CHECKPOINT INHIBITOR MBG453
  • ANTI-TIM-3 MONOCLONAL ANTIBODY MBG453
  • IMMUNOGLOBULIN G4 (226-PROLINE,DE-C-TERMINAL-LYSINE), ANTI-(HUMAN HEPATITIS VIRUS A CELLULAR RECEPTOR 2) (HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS260714 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS260714 .KAPPA.-CHAIN, DIMER
  • IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS HAVCR2 (HEPATITIS A VIRUS CELLULAR RECEPTOR 2, T-CELL IMMUNOGLOBULIN MUCIN FAMILY MEMBER 3, TIM-3, TIM3, TIMD3, CD366)), HUMANIZED MONOCLONAL ANTIBODY
  • MBG453
  • MBG-453
  • NVP-MBG453
  • SABATOLIMAB [INN]
  • SABATOLIMAB [JAN]
  • SABATOLIMAB [USAN]
  • SABATOLIMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.




About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

Powered by

DNAnexus official logo